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Learning Objectives:  
Learners will be able to:  
 1) create motivation-based, recovery-oriented treatment 
plans for co-occurring disorders 
2) describe how to integrate recovery-oriented practices 
into their work, including dual recovery therapy, 
mindfulness-based interventions, MET, community 
resources, and 12-Step Facilitation 
3) Case Example: Tobacco Use Disorder & Schizophrenia  
  
COD: Common & Complex 
● High Rates of COD 
● Many Combinations of Psychiatric Diagnoses 
● Increased Consequences 
 
Integrated COD Treatment 
● COD treatment outcomes improve with 
integrated treatments, programs, and 
coordinated systems and services 
● Blend Psychosocial Treatments 
● Medications for both MI & SA 
→Numerous Resources: SAMHSA Principles, CO-MAP, 
SAMHSA TIPS, APA & VA practice guidelines 
● Recovery Orientation 
→Wellness oriented – tobacco, obesity, & stress 
 
SAMHSA 14 Principles 
1. Engagement 
 - welcome, access, meds & psychosocial 
treatment, community options and education 
2. Relationship Building 
 - collaborator in recovery process, empathic, 
hopeful, strength based, process of 
assessment and reassessment 
3. Shared Decision Making 
 - partnership, prognosis, risks & benefits, 
understanding of options, document process 
HHS Publication No. SMA-12-4689 
Shared Decision Making 
Shared Decision Making  
Online Tool: Tobacco Cessation 
and choice to use medicine 
● Online Interactive Tool for Consumers 
● Are you Ready to quit smoking?   
● Guides consumer through options, what matters to 
them, and helps them to make a decision.  
● Tool to talk with clinician or loved ones about 
decision 
● http://www.healthwise.net/cochranedecisionaid/Conten
t/StdDocument.aspx?DOCHWID=te7959 
 
 
 
Psychology of Taking 
Medications 
● “Pills Fix Problems” 
● Soothing – Quick  
● Switch / Add an addiction in vulnerable 
individual 
● How does it fit in working my program? 
● Manage aversion to taking medications 
once in recovery for addiction 
● Substances alter impact of Medications 
SAMHSA 14 Principles 
(continued) 
4. Screening & Assessment 
 - mental health, substance use, physical  
 - adherence monitoring 
 - laboratory findings 
5. Assessment of Co-Occurring Disorders 
→ Timeline – input from significant others 
→ Substance induced disorders  
→ Past History, Family History 
6. Integrated Interventions 
 - both “primary”  
 - best practices – psychosocial & meds  
 
  
DSM-5 Criteria for Substance Use Disorders:  
11 criteria (no abuse or dependence) 
Hasin DS, et al. Am J Psychiatry. 2013;170(8):834-851. PMID: 23903334 
DSM-5 Substance-Related 
and Addictive Disorders 
●Substance Use Disorders (SUD)  
→11 criteria 
→Severity (3 levels):  
→Mild: 2-3 symptoms  
→Moderate: 4-5  
→Severe: >6  
→No poly-substance category 
→each substance a unique disorder 
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition: 
DSM-5. Washington, DC: American Psychiatric Association; 2013. 
Ongoing COD Assessments:  
Dual Recovery Status Exam 
● Assess current mental status 
→Psychiatric symptoms & withdrawal symptoms 
● Assess last substance use  
→Cravings/thoughts 
● Assess for motivational level/changes  
● Assess treatment involvement 
→Medication compliance 
→Therapy 
→12-step/recovery activities 
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Integrated Psychosocial:  
Dual Recovery Therapy  
● Integrate and modify 4 traditional addiction 
psychosocial treatments 
→Motivational Enhancement Therapy 
→Relapse prevention 
→12-Step facilitation 
→Mindfulness based interventions 
● Blend evidence-based mental illness treatments  
→CBT 
→Social Skills Training 
● Individual, group, couples, family therapy 
● Many subtype examples: Seeking Safety, etc 
•DRT in MISSION 
•www.missionmodel.org 
 
•The Treatment Manual        &       The Consumer 
Workbook 
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MISSION-VET Implementation Materials 
SAMHSA 14 Principles 
(continued) 
7. Treatment Readiness 
 - likely different levels of motivation 
 - monitor for relapse 
8. Interdisciplinary Communication 
  - regular communication, team orientation, 
consistent message  
9. Integrated Treatment 
  -  individualized treatment plan through person-
centered planning process 
Case Example #1: 
Schizophrenia & 
Tobacco Use Disorder 
● 39 year old male patient  
→Doesn’t want to quit now, but willing to listen  
→Stable on Olanzapine 20mg per day 
→Other medical problems:  obesity & hypertension 
● Medical Examination  
→Expired CO = 43 
→BP 132 / 82 
● Social and Family Histories: 
→Single & lives in group home with many smokers 
→No history of alcohol or drug use 
→Drinks 8 cups of coffee per day 
Assessment & Treatment Plan 
● Mental Health Assessment – MSE, meds, strengths 
● Tobacco Use Assessment (Current & Past) 
→What using? how much?  
→Heaviness scale: TTF & Cig/day 
→Assess patterns of use – triggers, associations 
→CO meter or cotinine level 
● Past quit attempts 
● Current motivational level to quit / to engage in treatment 
● Support or lack of support – social network 
● Other medications, caffeine, substances & medical 
problems 
Emerging Tobacco Products:   
Smokeless Tobacco Products 
Electronic Cigarettes (E-Cigs) 
E-Cigarette  
● Not FDA approved  
● Not proven as cessation aides – 
patients may use 
● Could be harmful &/or addictive 
● Attracting adolescents 
→Thousands of flavors, including 
candy, chocolate, bubble gum 
● Technologically appealing 
● Cost   
→$140 one month supply 
Emerging Tobacco  
Products 
● Hookahs and water pipes 
● Little cigars 
 
 
Past Quit Attempts 
● Create timeline 
→Dates for each quit attempt 
● Reason for quit attempt 
● Method used to quit 
● Duration using that method 
● Withdrawal symptoms 
● Understanding of relapse 
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Case - Tobacco History   
● Started smoking at age 14 
● Smokes 40 cigarettes per day 
● Smokes in middle of night at times 
● Smoke first cigarettes in 1 minute of waking 
● 3 previous quit attempts 
→Quit for 4 weeks as part of acute hospitalization 
→Gum didn’t work 3 years ago 
→Tried Patch to quit about 9 months ago  
→Smoked with patch 
● Currently ambivalent about starting to quit now 
 
Assessing Motivation  
to Change 
● Assessment strategies:  
→Importance, readiness, and confidence rulers 
→DARN-C   (Desire, Ability, Reason, Need, and Commitment) 
→Decisional balance 
→Time-line/quit date 
→Counter-transference and non-verbal cues 
● What level of motivation? Precontemplation, 
contemplation, preparation, action, maintenance 
● Formal tools: SOCRATES and URICA 
 
SOCRATES = Stages of Change Readiness and Treatment Eagerness Scale; URICA = University of 
Rhode Island Change Assessment;  Prochaska JO, et al. Am Psychol. 1992;47(9):1102-1114.  
Treatment Plan 
● Schizophrenia to problem list  
● Add Tobacco Use Disorder to problem list 
→Consider motivational level 
● Educational materials 
→Resources (Health and other consequences/benefits) 
● Psychosocial treatment 
→What can you integrate?   
● Medication treatment 
→Monotherapy 
→Combination therapy 
● Community resources 
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Strategies for Lower-Motivated  
●Feedback Tools & MET 
●Behavioral Disconnects 
●Wellness and Recovery Groups 
→Learning About Healthy Living Groups 
●Nicotine Anonymous 
 
 
Personalized Feedback:  
What Matters  
● Carbon monoxide meter score 
and feedback  
→Big impact on patients 
→Short- & long-term benefits to quit 
● Yearly cost of cigarettes 
● Medical conditions affected by 
tobacco 
● Links with other substance abuse 
& relapses 
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Steinberg ML, Ziedonis DM, et al. Journal 
of Consulting and Clinical Psychology. 
2004;72(4):723-728. No PMID. 
Advise: Relevance of Quitting 
● Personalize the 
message 
→Better health 
→Fresher breath  
→More money 
→Role model 
→Freedom 
→More energy  
● Impact on their family and 
social life 
→Environmental tobacco 
smoke  
(pets, friends, family, 
children, etc) 
 
● Financial  
→Fewer sick days from 
work 
→Cost of cigarettes 
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MET = MI + Feedback 
● Motivational Interviewing  (Style) 
→Empathy, respects readiness to change, embraces 
ambivalence, and directive 
→OARS: Open-ended questions; affirmations; reflective 
listening; summaries 
● Personalized Feedback (Content) 
→Assessment, including motivational level 
→Decisional balance: pros and cons 
→Personalized feedback  
→Change plan, shared decision-making, and menu of 
options 
 MET = Motivational interviewing and personalized feedback 
                                                                       
  
Learning 
About  
Healthy  
Living 
TOBACCO AND YOU 
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Free  
Online 
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 For Lower 
& Higher 
Motivated   
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Case Continues:  
● Excellent progress in LAHL group & your 
use of personalized feedback. Now 
interested to quit and willing to try 
medications. Modify the Treatment Plan 
 
● What Medication, Psychosocial Treatments, 
Community Resources would you consider?  
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SAMHSA 14 Principles 
(continued) 
10. Pharmacological Strategies & Drug 
Interaction / Toxicity 
 
11. Medications & Crossover Benefits 
 
12. Risk / Benefit Assessment 
 
SAMHSA 14 Principles 
(continued) 
13. Coordinated Treatment Approach 
 - medical comorbidities 
 - coordinated treatments 
 
14. Relapse Prevention 
 - monitor signs of relapse 
 - relapse analysis 
Updated Treatment Plan 
● Schizophrenia & Tobacco Use Disorder on problem list 
→update enhanced motivational level 
● Educational materials 
→Resources / Health and other consequences/benefits 
● Psychosocial treatment 
→What can you integrate?   
● Medication treatment 
→Monotherapy 
→Combination therapy 
● Community resources 
→Peer Support Specialists / NicA 
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Strategies for Higher Motivated  
● 7 FDA-approved medications 
→Five nicotine replacement therapies (NRTs)  
→Patch, gum, spray, lozenge, inhaler 
→Bupropion  
→Varenicline  
● Psychosocial treatments 
→Cognitive-behavioral therapies 
→Mindfulness-based interventions  
→Social support 
● Community resources  35 
CBT: Relapse Prevention 
● Identifying cues / triggers for substance use or 
cravings / thoughts 
● Do an analysis of a “relapse” 
● Goal to improve self-efficacy to avoid / handle 
specific people, places, things, moods, other 
addictive acts, etc 
● Examples: Drug refusal skills, seemingly 
irrelevant decisions, managing moods / thoughts, 
and stimulus control 
CBT = Cognitive Behavior Therapy 
Guichenez P, et al. Rev Mal Respir. 2007;24(2):171-182. PMID: 17347604. 
Integrating Mindfulness into 
Clinical Practice 
● Enhanced Presence & Listening 
→Brief 5 minute Moments  
● Mindfulness Based Stress Reduction (MBSR) 
● Acceptance and Commitment Therapy (ACT) 
● Mindfulness-Based Cognitive Therapy (MBCT) 
● Dual Recovery Therapy (DRT) 
● Dialectical Behavior Therapy (DBT) 
→“what” and “how” skills 
● Mindfulness Based Relapse Prevention (MBRP)  
→Addiction Treatment & 12-Step Recovery  
● Apps & websites & mp3s    
Applied Mindfulness: RAIN 
● Recognize 
→“I’m feeling anxious” 
● Accept/allow 
→See if you are resisting the experience 
● Investigate 
→“What’s happening in my body right now?” 
● Note 
→Label or mentally note the body sensations from moment to 
moment 
Brewer JA, et al. Psychol Addict Behav. 2013 Jun;27(2):366-379. PMID: 22642859   
http://www.mindful.org/mindful-magazine/craving-to-quit, Judson Brewer, MD, PhD author 
Community Resources 
● Quit lines (phone) 
→1-800-QUIT-NOW 
● Online (internet / apps) 
→www.becomeanex.org 
→www.quitnet.com 
→www.ffsonline.org 
● Local treatment groups 
● Nicotine Anonymous 
→In person meetings 
→Telephone meetings 
→Internet meetings 39 
12-Step Facilitation 
● Accepts disease model 
● Encourages use of 12-Step social network, including 
sponsor and home group 
● Coach “working their program” 
● Fellowship and higher power are the agents of 
change - spirituality key 
● Initial labeling of self as alcoholic is encouraged to 
address denial, minimization, and rationalization 
● Abstinence model - loss of control with use 
● Acceptance, Surrender, and Get Active 
Is the Patient Working Their 
12-Step Program? 
● Working the steps 
● Sponsor, mentor, or guide 
● Group support and involvement 
● Self-evaluation 
● Spiritual Activity – Connection to Higher Power (prayer, 
meditation, ..) 
● Daily reading or reflections  
● Health care (recreation, exercise, diet, tobacco) 
● Celebrate successes 
● Being of service to others 
Dual Recovery Anonymous  
● Several different types of modified 12-step groups 
● Recovery concepts supports increased sense of hope and 
connection to others 
● Shared experience:  
→Eperience, Strength, & Hope) 
● 12-step phrases describe complex concepts in simple and 
easy way to remember 
→One day at a time 
→Stinking thinking 
→HALT (Hungry, Angry, Lonely, Tired) 
→Serenity prayer 
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Peer Support Specialists 
● Consumer involvement on leadership 
committees, treatment, and engagement 
● Genesis Club House 
● www.NJChoices.org 
● www.Rxforchange.org 
● Wellness & Health Fairs 
43 
Principles of Pharmacology for 
Mental Illness in COD  
● Avoid psychiatric medications with:  
→abuse liability 
→overdose risk 
→causing seizure 
→Sedation 
→liver toxicity 
● Simplify dosing strategies (start low – go slow) 
● Stress education and compliance 
● Minimize refills 
 
Principles of Pharmacology 
for COD  
● Specificity of psychiatric & addiction disorders 
● All medications are not created equal  
→Abuse liability - Benzos / Sedatives, 
Stimulants, Pain Medications  
→Safety - in general & when using substances  
● Interaction with substances 
→Ex. MAOI & Stimulants 
→Few studies / lots of natural experiments 
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Co-Occurring Disorder  
Pharmacotherapy in  
Mental Health Settings 
● Focus on treating the mental illness(es) 
● Shared decision on psychiatric medication(s) 
→Prior treatment, side effect profile, family history 
→Likelihood of adherence 
→Substance Use / Addiction considerations 
● Consider adding addiction treatment meds 
→Specific for treating an Alcohol, Tobacco & Other 
Drugs Use Disorder 
→Detox, Protracted Withdrawal, & Maintenance 
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Medication Treatments for  
COD in Addiction Settings 
● Substance Detoxification 
● Protracted abstinence 
● Harm reduction / opioid agonists 
● Co-occurring psychiatric disorders 
  
● Helpful Alcoholics Anonymous Brochure to 
give patients going to 12-Step Meetings:   
→The AA Member: Medications and Other 
Drugs, 1984 
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Medication Algorithm 
Considerations 
● Patient preference 
● Past experience 
→Failed monotherapy attempts  
→Incorrect administration of medication 
→Multiple failed attempts 
● Medical comorbidities 
● Severity of withdrawal & dependence 
● Breakthrough cravings 
● Oral cravings/hand-to-mouth motion 
● Weight gain concerns 
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Medication Algorithm 
● Monotherapy (any of 7 FDA med choices) 
→Varenicline  
→Patch 
→Oral NRT  
→Bupropion 
● Combination pharmacotherapy 
→Multiple NRTS 
→Patch and oral NRT 
→Bupropion & NRT 
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Rationale NRT Replacement 
Pharmacology 
● Each cigarette contains about 13 mgs nicotine  
→About 1 – 3 mgs of nicotine are absorbed per cigarette 
● SMI tend to absorb the 2 – 3 mgs nicotine per cigarette 
→Higher CO and cotinine levels than expected 
● Some practitioners and researchers match cotinine level 
to nicotine replacement dosage 
● Example:  
→3 packs per day = 20 cigarettes times 2 mgs per cigarette times 3 
packs per day = 120 mgs nicotine 
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Tobacco Smoke & Psychiatric 
Medication Blood Levels 
● Smoking induces the P450 1A2 isoenzyme secondary 
to the polynuclear aromatic hydrocarbons  
● Smoking increases metabolism of:  
→Haloperidol, fluphenazine, olanzapine, clozapine, 
thioridazine, chlorpromazine, etc 
→Caffeine is metabolized through 1A2  
● Check for medication side effects  
● Nicotine use alone (versus tobacco smoking) does not 
change medication blood levels (2D6) 
→Nicotine replacement therapy (NRT) does not affect 
medication blood levels  
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Reluctance to Prescribe 
Psychiatric Medications to 
Substance Abusers 
● Worries about Toxic interaction 
● Medication effect negated by drugs of 
abuse 
● Manipulation 
● Treating substance-induced symptoms 
● Enabling 
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SAMHSA Pharmacotherapy 
Principles (2012) 
● General Principles for the Use of 
Pharmacological Agents to Treat 
Individuals with Co-Occurring Mental and 
Substance Use Disorders 
● 14 Principles for Prescribers 
● HHS Publication No. SMA-12-4689 
http://store.samhsa.gov/product/Pharmacologic-Guidelines-for-Treating-
Individuals-with-Post-Traumatic-Stress-Disorder-and-Co-Occurring-Opioid-
Use-Disorders/SMA12-4688 
